| Status | Study |
| Not yet recruiting |
Study Name: Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma Condition: Adult Burkitt Lymphoma B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between D Date: 2015-05-26 Interventions: Drug: Cyclophosphamide Given I |
| Active, not recruiting |
Study Name: Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant Condition: Adult Grade III Lymphomatoid Granulomatosis B-cell Chronic Lymphocytic Leukemia Date: 2014-01-14 Interventions: Drug: bortezomib Given IV |
| Completed |
Study Name: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-10-08 Interventions: Drug: busulfan Given IV |
| Recruiting |
Study Name: Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma Condition: AIDS-related Non-Hodgkin Lymphoma AIDS-related Plasmablastic Lymphoma Date: 2013-09-09 Interventions: Drug: busulfan Given IV |
| Active, not recruiting |
Study Name: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-27 Interventions: Drug: brentuximab vedotin Give |
| Recruiting |
Study Name: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-13 Interventions: Other: questionnaire administration |
| Completed |
Study Name: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission Date: 2013-02-07 Interventions: Drug: vorinostat Given PO |
| Completed |
Study Name: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies Condition: Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Date: 2011-01-07 Interventions: Drug: deferasirox Given orally |
| Completed |
Study Name: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Condition: Hematopoietic/Lymphoid Cancer Accelerated Phase Chronic Myelogenous Leukemia Date: 2010-09-08 Interventions: Procedure: infection prophylaxis and management |
| Completed |
Study Name: RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2010-07-07 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |